Onye isi sayensị
Wenqiang Yu, Ph.D.
●Onye isi sayensị nke National "973" Mmemme;
●Prọfesọ ahọpụtara nke ọma maka Mmemme Ọkachamara Chang Jiang;
●PI, Center for Epigenetics, Institute of Biomedical Sciences University Fudan;
●Onye nyocha ahọpụtara nke ọma na onye nlekọta doctoral nke Mahadum Fudan;
●Onye ndu nke Kọmitii Ọkachamara Methylation Marker nke Kọmitii Marker Tumor nke Òtù Na-ahụ Maka Ọrịa Cancer nke China.
Na 1989, ọ gụchara na Fourth Military Medical University wee nweta nzere bachelọ na ọgwụ;
N'afọ 2001, ọ natara akara ugo mmụta doctorate na mahadum nke anọ nke agha;
Site na 2001-2004, nwetara Postdoctoral na Department of Development and Genetics, Uppsala University, Sweden;
Site 2004-2007, nwetara Postdoctoral na Hopkins University School of Medicine, United States;
Ugbu a, Prọfesọ Yu bụ PI na onye nyocha nke Institutes of Biomedical Sciences nke Mahadum Fudan, yana onye isi osote onye isi oche nke Institute of Genomics na Epigenomics nke Mahadum Fudan.Ebipụtala ihe ndị ọ rụpụtara n'ime nyocha n'akwụkwọ akụkọ agụmakwụkwọ kacha elu nke mba ụwa dịka,Ọdịdị, Genetics okikenaJAMA.
bilitere na akwụkwọ akụkọ agụmakwụkwọ kachasị elu nke mba ụwa dị ka Nature, Nature Genetics na JAMA, nwere mmetụta kachasị elu nke isi 38.1.
CEO
Lin Hua
Bachelor of Economics nke Shanghai JiaoMahadum Tong.Ọ rụrụ ọrụ dị ka onye isi njikwa nke ngalaba ụlọ ọrụ edepụtara aha nke Guosen Securities, onye mmekọ nke XIANGDU CAPITAL, onye mmekọ ntọala nke CHOBE CAPITAL.Dị ka onye ndu otu, ọ kwalitela itinye ego n'ọtụtụ ụlọ ọrụ na-aga nke ọma.
ObiO (688238): Onye nrụpụta CGT CDMO nwere ikike kachasị ukwuu;
Novoprotein (688137): onye na-eweta akụrụngwa na-elekwasị anya na protein recombinant;
Leadsynbio: ụlọ ọrụ na-eduga na bayoloji sịntetik;
SinoBay: ụlọ ọrụ na-ahụ maka ọgwụgwọ tumor ezubere iche
Quectel(603236): ụlọ ọrụ nzikọrịta ozi ikuku kachasị n'ụwa
XinpelTek: lekwasị anya na ụlọ ọrụ mgbawa PA RF ikuku;
DGene: lekwasị anya na ụlọ ọrụ dijitalụ 3D
Vidiyo++: ụlọ ọrụ unicorn na mpaghara AI
N'ihe karịrị otu afọ n'ahịa isi obodo, Ms Hua achịkọtala nnukwu ahụmịhe na njikwa ụlọ ọrụ na itinye ego.
Onye isi R&D
Wei Li, Ph.D.
Dọkịta Li rụrụ ọrụ dị ka onye nyocha mmekọrịta na Institute of Biological Science Fudan University afọ iri.Ọ na-elekọta ọrụ nyocha 3 gụnyere National Natural Science Foundation of China,oru nyocha nke onwe nke iwebata talentna wdg.Ọ sonyekwara ọtụtụ ọrụ mba, gụnyere National 973 Project, Key Project of National Natural Science Foundation na ihe ndị ọzọ.O bipụtala akwụkwọ 16 SCI dị ka onye edemede mbụ ma ọ bụ odee kwekọrọ na yaNnyocha genome, eBiomedicine, Acid nuklia Nyocha na wdg.(Mkpokọta Mmetụta Mmetụta 158.97).
Isi mmasị nyocha:
1. Mmepe nke epigenetic algọridim na multi-omics ọmụmụ nke tumo pathogenesis.Otu mkpebi otu isi ihe niile genome-wide DNA methylation sequencing analysis platform (WGPS algọridim) ka emebere na mbido mbụ.Mgbe ahụ, enwetara maapụ DNA methylation nke mbụ nke mkpụrụ ndụ imeju mmadụ.Ka ọ dị ugbu a, o nyere usoro ọhụrụ nke akpụ na-egbochi mkpụrụ ndụ ihe nketa ịgbachi nkịtị na echiche epigenetics.
2. Nyochaa ndị na-ahụ maka biomarkers nke omume ọjọọ n'ọtụtụ ụdị ọrịa kansa site na data multi-omics.Dabere na usoro WGPS, anyị nyochara akara hypermethylation pụrụ iche n'etiti etuto na nkịtị.
3. Nchọpụta na pathogenesis nke mkpụrụ ndụ ihe nketa transcriptional activation site na NamiRNA: Otu klas nke miRNA nuklia, nke anyị kpọrọ NamiRNA (Nuclear Activating miRNA).
Injinia R&D Medical
Meigui Wang, Ph.D.
Dọkịta Wang nwetara Ph.D.ogo sitere na Mahadum South Medical University na 2019. Ọ gara n'ihu na-agbaso ọzụzụ ọkọlọtọ nke ndị bi na ụlọ ọgwụ nke atọ nke Mahadum Sun Yat-sen (2019-2021).Mmasị ụlọ ọgwụ ya bụ nyocha na ọgwụgwọ ọrịa kansa isi na olu dịka kansa laryngeal na nasopharyngeal carcinoma.Ihe gbasara nyocha ya na-elekwasị anya na nchọpụta mmalite nke carcinoma nasopharyngeal.
Injinia R&D Medical
Yaping Dong, Ph.D.
Dọkịta Dong nwetara Ph.D.ogo mmụta ọgwụ na ọgwụ ahụike sitere na Mahadum Fujian Medical na 2020, wee mee nyocha post-doctoral na Mahadum Fudan Shanghai Cancer center site na 2020 ruo 2022. Dị ka onye isi sonyere, ọ sonyere ọtụtụ ọrụ mba, gụnyere Ministry of Science and Technology Key Programme maka “ Ọhụrụ dị ịrịba ama mmepe mmepe", National Natural Science Foundation of China na na.O bipụtala ọtụtụ akwụkwọ dị elu na Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica na Radiation Oncology.